We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$25.8B
AUM Growth
+$4.56B
Cap. Flow
+$3.3B
Cap. Flow %
12.77%
Top 10 Hldgs %
19.43%
Holding
1,157
New
287
Increased
424
Reduced
242
Closed
147

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$997M
2
TXN icon
Texas Instruments
TXN
+$215M
3
NVDA icon
NVIDIA
NVDA
+$209M
4
VZ icon
Verizon
VZ
+$208M
5
APH icon
Amphenol
APH
+$143M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$200M
2
MRUS
Merus
MRUS
+$158M
3
ALL icon
Allstate
ALL
+$141M
4
CB icon
Chubb
CB
+$115M
5
ARGX icon
argenx
ARGX
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 23.32%
3 Financials 10.75%
4 Consumer Discretionary 10.22%
5 Communication Services 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRI icon
1001
Darden Restaurants
DRI
$24.1B
$208K ﹤0.01%
+1,130
New +$206K
LYB icon
1002
LyondellBasell Industries
LYB
$19.8B
$204K ﹤0.01%
+4,707
New +$213K
ANTX icon
1003
AN2 Therapeutics
ANTX
$219M
$166K ﹤0.01%
+145,971
New +$170K
SNAP icon
1004
Snap
SNAP
$8.83B
$160K ﹤0.01%
+19,842
New +$157K
DAVA icon
1005
Endava
DAVA
$154M
$155K ﹤0.01%
24,522
-5,707
-19% -$43.7K
CNH
1006
CNH Industrial
CNH
$17.4B
$149K ﹤0.01%
+16,134
New +$161K
KALA icon
1007
KALA BIO
KALA
$14.2M
$125K ﹤0.01%
4,483
-466
-9% -$20.9K
FHTX icon
1008
Foghorn Therapeutics
FHTX
$327M
$116K ﹤0.01%
21,523
-87,073
-80% -$395K
CASI
1009
DELISTED
CASI Pharmaceuticals
CASI
$113K ﹤0.01%
133,406
-32,234
-19% -$41.7K
NMRA icon
1010
Neumora Therapeutics
NMRA
$304M
$26.8K ﹤0.01%
14,957
ACAD icon
1011
Acadia Pharmaceuticals
ACAD
$4.9B
-151,453
Closed -$3.23M
AIT icon
1012
Applied Industrial Technologies
AIT
$13.3B
-6,233
Closed -$1.63M
AKRO
1013
DELISTED
Akero Therapeutics
AKRO
-639,598
Closed -$30.4M
ALIT icon
1014
Alight
ALIT
$411M
-3,131
Closed -$204K
ALRM icon
1015
Alarm.com
ALRM
$2.78B
-14,108
Closed -$749K
ALV icon
1016
Autoliv
ALV
$8.83B
-99,009
Closed -$12.2M
AMN icon
1017
AMN Healthcare
AMN
$1.19B
-990,514
Closed -$19.2M
AN icon
1018
AutoNation
AN
$6.99B
-54,544
Closed -$11.9M
APPN icon
1019
Appian
APPN
$2.23B
-172,776
Closed -$5.28M
ARCB icon
1020
ArcBest
ARCB
$3.02B
-25,857
Closed -$1.81M
ARKG icon
1021
ARK Genomic Revolution ETF
ARKG
$1.63B
-74,571
Closed -$2.07M
ATHM icon
1022
Autohome
ATHM
$2.62B
-38,221
Closed -$1.09M
AVNT icon
1023
Avient
AVNT
$3.91B
-243,490
Closed -$8.02M
AVTR icon
1024
Avantor
AVTR
$8.91B
-1,628,501
Closed -$20.3M
BABA icon
1025
Alibaba
BABA
$304B
-21,995
Closed -$3.93M

Similar funds

Woodline Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Woodline Partners held 1,157 positions worth $25.8B, up 21% from $21.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Woodline Partners deployed $3.3B of net new capital in Q4 2025, opening 287 new positions and adding to 424 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was AT&T, an estimated $200M trimmed.

  • Woodline Partners's largest Q4 2025 buy was iShares Core S&P 500 ETF: 1,467,676 shares worth $1.01B.
  • Woodline Partners added most to Texas Instruments in Q4 2025, an estimated $215M increase.
  • Woodline Partners's biggest Q4 2025 reduction was AT&T, cutting an estimated $200M.
  • Woodline Partners fully exited Merus in Q4 2025, selling an estimated $158M.
  • Woodline Partners's ten largest holdings make up 19% of its $25.8B portfolio in Q4 2025.
  • Woodline Partners opened 287 new positions and closed 147 in Q4 2025.
  • Woodline Partners's portfolio value rose 21% quarter-over-quarter to $25.8B.

Based on Woodline Partners's 13F filing for Q4 2025, filed 17 Feb 2026.